4HF Biotec provides services to support preclinical drug development. Our team of experts can help you to optimise experimental design of drug testing, for interpretation of the results and for biomarker discovery. For target identification, various analyses are available to reveal the true makeup of cancers and their vulnerabilities.

​

Whether it is to investigate the best cancer indications for drug testing, identifying response trends or investigating new targets or biomarkers, we tailor our work to your projects and final goals. If you have already your own database or have already identified drug candidate from other projects, your information can be used to extend the analysis via our platform. We can match your data in our database and make use of our proprietary integrative tools to enhance information on your targets.